Company profile: Epiontis
1.1 - Company Overview
Company description
- Provider of immune cell identification and quantification services with accuracy and technical ease, using a novel molecular diagnostics technology, offering worldwide services.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Epiontis
Athenix
HQ: United States
Website
- Description: Provider of crop science offerings in seeds, crop protection, and non-agricultural pest control, leveraging agricultural and industrial biotechnology and a gene-discovery infrastructure to develop products that meet real customer needs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Athenix company profile →
Renova Therapeutics
HQ: United States
Website
- Description: Provider of gene therapies for chronic diseases, focusing on cardiovascular and metabolic indications. Offerings include RT-100, a single-dose therapy to improve heart function in congestive heart failure; RT-200, a single intravenous therapy to normalize blood glucose in Type 2 Diabetes Mellitus; and paracrine gene therapy enabling systemic delivery of therapeutic genes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Renova Therapeutics company profile →
Multiplicom
HQ: Belgium
Website
- Description: Provider of molecular diagnostics products and clinical laboratory-based tests, including DNA/RNA library preparation and hybrid-capture target enrichment kits for Illumina sequencing. Offerings support low-input and FFPE samples, whole-genome and targeted sequencing, liquid biopsy applications, include molecular barcodes, and enable detection of low-frequency alleles.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Multiplicom company profile →
Signal Genetics
HQ: United States
Website
- Description: Provider of innovative molecular diagnostic services that help physicians make better-informed decisions in the care of patients with cancer; a commercial-stage molecular diagnostics company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Signal Genetics company profile →
GenomeSmart
HQ: United States
Website
- Description: Provider of an AI-powered genetic risk assessment, education, and matching platform that uses machine learning to generate personalized reports based on a person's profile, matching them to the right type of genetic tests and providing relevant details to simplify understanding of genetic testing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GenomeSmart company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Epiontis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Epiontis
2.2 - Growth funds investing in similar companies to Epiontis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Epiontis
4.2 - Public trading comparable groups for Epiontis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →